CTOs on the Move

Shifamed

www.shifamed.com

 
Shifamed is a Campbell, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.shifamed.com
  • 746 Camden Ave Suite A
    Campbell, CA USA 95008
  • Phone: 408.903.4090

Executives

Name Title Contact Details

Similar Companies

Seton Health System Inc

Seton Health is a comprehensive, integrated health care system, anchored by St. Mary's Hospital of Troy. We serve Rensselaer, Albany and Southern Saratoga counties from more than twenty locations in the greater Capital District area.

Animale Parfums

Animale Parfums is a Hollywood, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Patient First

Patient First is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Ra Medical

Advanced Excimer Laser-Based Vascular and Dermatological Therapies We are a medical device company leveraging our advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases. We believe our products enhance patients` quality of life by restoring blood-flow in arteries and clearing chronic skin conditions. We currently manufacture and market two lines of products: DABRA Catheter and Laser is cleared by the U.S. FDA as a tool for the minimally invasive endovascular treatment of vascular blockages resulting from lower extremity vascular disease, including peripheral artery disease (PAD) and critical limb ischemia (CLI). Pharos Excimer Laser is FDA cleared as a tool used in the treatment of inflammatory skin conditions, including psoriasis, atopic dermatitis, and leukoderma.

CASI Pharmaceuticals

CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.